[Neuromuscular rest blockades after a single dose of a mid-term muscle relaxant].
Schreiber
J U
JU
Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar. jan.schreiber@uniklinik-saarland.de
D000732:Androstanols / Q000009:adverse effects; D001279:Atracurium / Q000009:adverse effects; D004558:Electric Stimulation; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D016343:Monitoring, Intraoperative; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D010243:Paralysis / Q000453:epidemiology*; D011183:Postoperative Complications / Q000453:epidemiology*; D000077123:Rocuronium; D014673:Vecuronium Bromide / Q000009:adverse effects
D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D001279:Atracurium; D014673:Vecuronium Bromide; D000077123:Rocuronium